| Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report P Malfertheiner, F Megraud, CA O'Morain, J Atherton, ATR Axon, ... Gut 61 (5), 646-664, 2012 | 9046* | 2012 |
| The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects APS Hungin, PJ Whorwell, J Tack, F Mearin Alimentary pharmacology & therapeutics 17 (5), 643-650, 2003 | 1051 | 2003 |
| Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact APS Hungin, L Chang, GR Locke, EH Dennis, V Barghout Alimentary pharmacology & therapeutics 21 (11), 1365-1375, 2005 | 616 | 2005 |
| The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review AD Sperber, D Dumitrascu, S Fukudo, C Gerson, UC Ghoshal, KA Gwee, ... Gut 66 (6), 1075-1082, 2017 | 478 | 2017 |
| Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review A Raghunath, APS Hungin, D Wooff, S Childs Bmj 326 (7392), 737, 2003 | 424 | 2003 |
| Inflammatory bowel disease: epidemiology and management in an English general practice population GP Rubin, APS Hungin, PJ Kelly, J Ling Alimentary pharmacology & therapeutics 14 (12), 1553-1559, 2000 | 421 | 2000 |
| Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study A Fuat, APS Hungin, JJ Murphy Bmj 326 (7382), 196, 2003 | 391 | 2003 |
| New algorithm for the treatment of gastro‐oesophageal reflux disease GN Tytgat, K McColl, J Tack, G Holtmann, RH Hunt, P Malfertheiner, ... Alimentary pharmacology & therapeutics 27 (3), 249-256, 2008 | 353 | 2008 |
| Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice–an evidence‐based international guide APS Hungin, C Mulligan, B Pot, P Whorwell, L Agréus, P Fracasso, ... Alimentary pharmacology & therapeutics 38 (8), 864-886, 2013 | 286 | 2013 |
| Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population TM Kennedy, RH Jones, APS Hungin, H O’flanagan, P Kelly Gut 43 (6), 770-774, 1998 | 276 | 1998 |
| Evolving general practice consultation in Britain: issues of length and context GK Freeman, JP Horder, JGR Howie, AP Hungin, AP Hill, NC Shah, ... Bmj 324 (7342), 880-882, 2002 | 274 | 2002 |
| Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K) S Alshryda, J Mason, M Vaghela, P Sarda, A Nargol, S Maheswaran, ... Jbjs 95 (21), 1961-1968, 2013 | 266 | 2013 |
| Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology RP Arasaradnam, S Brown, A Forbes, MR Fox, P Hungin, L Kelman, ... Gut 67 (8), 1380-1399, 2018 | 242 | 2018 |
| The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure A Fuat, JJ Murphy, APS Hungin, J Curry, AA Mehrzad, A Hetherington, ... British Journal of General Practice 56 (526), 327-333, 2006 | 239 | 2006 |
| Gastro-oesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings RH Jones, APS Hungin, J Phillips, JG Mills The European Journal of General Practice 1 (4), 149-154, 1995 | 200 | 1995 |
| Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H) S Alshryda, J Mason, P Sarda, A Nargol, N Cooke, H Ahmad, S Tang, ... JBJS 95 (21), 1969-1974, 2013 | 195 | 2013 |
| A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome EMM Quigley, H Abdel-Hamid, G Barbara, SJ Bhatia, G Boeckxstaens, ... Journal of clinical gastroenterology 46 (5), 356-366, 2012 | 192 | 2012 |
| The fight for ‘health-related normality’: a qualitative study of the experiences of individuals living with established inflammatory bowel disease (IBD) NJ Hall, GP Rubin, A Dougall, APS Hungin, J Neely Journal of health psychology 10 (3), 443-455, 2005 | 178 | 2005 |
| Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. AP Hungin, G Rubin, H O'Flanagan British Journal of General Practice 49 (443), 463-464, 1999 | 148 | 1999 |
| Systematic review: probiotics in the management of lower gastrointestinal symptoms–an updated evidence‐based international consensus APS Hungin, CR Mitchell, P Whorwell, C Mulligan, O Cole, L Agréus, ... Alimentary Pharmacology & Therapeutics 47 (8), 1054-1070, 2018 | 145 | 2018 |
